Patients
Physicians
Pharmaceutical Companies
Why Aureon?
Applications
Case Studies
Prostate Cancer
Lung Cancer
 

Prostate Cancer Case Studies 


Prostate cancer affects approximately 600,000 men worldwide every year, with ~200,000 new cases occurring in the United States annually.

Targeted therapeutics are providing a promising view of the future for prostate cancer. Here are case studies of how Aureon has worked with pharmaceutical companies to investigate personalized therapeutic approaches for prostate cancer.

Case Studies HTML PDF
Prediction of Duration of Response to Androgen Deprivation Therapy   HTML version   PDF (429KB)
Quantitation of Infiltrating Lymphocytes Post Immunotherapy   HTML version   PDF (1MB)